When can XARELTO (rivaroxaban) generic drug versions launch? Generic name: rivaroxaban DrugPatentWatch® Estimated Key Patent Expiration / Generic Entry Date: February 28, 2025 Generic Entry Controlled by: United States Patent Patent 7,157,456 XARELTO is a drug marketed by Janssen Pharms. ...
Procedures for a Registration Authority operating on behalf of countries to register organization names subordinate to country names in the X.660 RH-name-tree 热度: A person´s name is very important. Some names also have 热度: 《英语姓名词典》与外国人名翻译问题(English name dictionary and...
Xarelto Xeljanz Xenical Xiidra Xtandi Xtane Xultophy Yasmin Yazz Zeffix Zeldox Zepdon Ziagen Zofran Zydis Zoladex Zolmist Zomig Zovirax Zurig Zyban Zycolchin ZyprexaWhat Our Clients And Partner Have To Say About Us "Super happy with professional customer service, I ordered Forziga and they delive...
Janssen PharmsXARELTOrivaroxabanTABLET;ORAL022406-004Oct 11, 2018RXYesNo⤷Subscribe⤷Subscribe >Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration ...